BMS to cut 2,200 jobs in $1.5B restructuring as Opdivo sales drop in Q1
AstraZeneca leaps after smashing first-quarter forecasts
CureVac initiates H5N1 avian influenza vaccine study
Regeneron expands in gene editing with Mammoth deal
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
AstraZeneca leaps after smashing first-quarter forecasts
CureVac initiates H5N1 avian influenza vaccine study
Regeneron expands in gene editing with Mammoth deal
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud